BSX three-lens brief
Evidence-based stock research on BSX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Price down 5.51% in the last session — a material single-day move. · Trading at 5% of its 52-week range — deep in the lower band.
- Price down 5.51% in the last session — a material single-day move.
- Trading at 5% of its 52-week range — deep in the lower band.
- Underperforming SPY by 16.6pp over 30 days.
- Analyst mean target $87.06 — 40% above current (31 analysts).
- Debt-to-equity of 48.9 — balance-sheet-heavy.
BSX closed at $62.07 (-5.51%) as of 2026-04-25. Market cap: $92.25B. P/E (trailing) 26.0. Positives: analyst mean target $87.06 — 40% above current (31 analysts).. Concerns: price down 5.51% in the last session — a material single-day move.; trading at 5% of its 52-week range — deep in the lower band.. Last quarter: Revenue $5.20B, net income $1.34B.
Why three lenses on BSX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BSXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BSX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BSX brief"></iframe>